Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
125 Cards in this Set
- Front
- Back
important invasive factor
|
IgA protease
|
|
agglutinins and typical Ig
|
clump bacteria, enhance their removal- usually IgM
|
|
opsonins and typical Ig
|
enhance phagocytosis,
Ab coated microbes attach to Fc receptor on phagocytic cells (M/M, neuts) --- IgG most often also- complement helps |
|
Abs that activate complement
|
IgM and IgG
|
|
neutralizing Abs do what and typical Ig
|
AB THAT NEUTRALIZE VIRUSES OR BIOLOGIC ACTIVITY OF BACTERIAL TOXINS
IgG, IgA |
|
lysins and typical ig
|
CAUSE DISRUPTION OF CELL MEMBRANES ESPECIALLY IN CONJUCTION WITH THE C SYSTEM (IgG, IgM)
|
|
anti-adherence Ig and example
|
PREVENT ATTACHMENT OF MICROBES TO CELLS OR HARD SURFACES. FOR EX. SIgA IN SALIVA PREVENTS BACTERIA FROM ADHERING TO SURFACES OF TEETH
|
|
what is ADCC?
|
antibody-dependent cell-mediated cytotoxicity
- NK binds to Fc portion of antibody bound to pathogen and NK will release contents onto infect cells - primary way NK cells kill |
|
active defense mechanisms at mucosal surfaces
|
mammary gland, gastrointestinal, respiratory, urogenital
- skin isn't active |
|
components of GI immunology (physical// chemical/ biological barrier)
|
mucous- binds lectins on pathogen surface (contains defensins that poke holes)
cilliary actions pH enzymes/ antimicrobial peptides (lysozyme) leukocytes at the ready incase physical barrier is bypassed |
|
components of GI immunology (secondary)
|
GALT
- epithelial - lamina propria - mesenteric lymph nodes |
|
oral lymphoid tissues
|
- waldeyer's ring
- adenoids - palatine tonisils - lingual tonsits - produce secretory IgA |
|
components of intestinal mucosal tissues
|
- effector cells populate healthy intestinal epithelium and lamina propria
- peyer's patches (effector cells not yet active) - lymphoid follicles - draining lymphatics from villi to mesenteric lymph nodes - LP has mature, active B and T cells (75% in gut- main area |
|
M cells
reside: take up antigen by: Ag transported by: antigen then bound by: |
- in columnar epithelial along with enterocytes
- endocytosis/phagocytosis - taken in vesicles and released at basal surface - bound by dendritic cells, present to T cells - lead into peyer's patches (act like regular LN) |
|
cell that can extend into gut lumen to capture antigen
- rest of its body sits in: |
activated lamina propria dendritic cells
sits in peyer's patch so it can be ready to present |
|
active effector cells in gut is constantly making _____ to protect system
|
IgA
|
|
effector cytotoxic lymphocytes that can integrate into the intestinal epithelia
- whatever it binds, it kills can be alpha:beta or gamma:delta |
intestinal epithelial lymphocytes
|
|
special things about mucosal immune system
- effector cells migrate: - macrophages don't contain ______ and don't generate ___________ - function to _______ not _____ microorganisms |
effector cells always migrate back to mucosa
macs don't contain TLRs --> no inflammation restrain, not remove (we like commensal bacteria) |
|
naive B and T cells that migrate through teh GALT (are/are not) specific for GALT
|
not specific until activated to become GALT specific
|
|
gut-homing effector T cells bind to ___________ to enter lamina propria
in lamina propria, they bind to _______ expressed by __________ making it __________ |
- bind to intestinal vascular endothelium
- bind to chemokines (CCL225) expressed by intestinal epithelium - embed in epithelia |
|
factor that allows gut-homing into lamina propria
factor for embedding into epithelia |
L-selectin & alpha4: beta7 to MAdCAM-1 on endothelium
E-cadherin on epithelium |
|
Abs passed to baby through breast milk
|
IgA- activated in gut, is specific for all mucosa, can circulate to mammary glands then give baby Gut-specific immunity
|
|
roles for secreted IgA
|
- can export toxins from LP when secreted
- bind and neutralize Ags internalized in endosomes - stick in mucous, can bind to toxins, bacteria, neutralizing pathogens until it gets clipped/passes through - can bind pathogen on M cell and take it to lymphoid tissue - picks up Ag in endosome of M cell then take to LN tissue |
|
why do we have two forms of IgA?
|
IgA1 has longer hinge region- often cleaved by proteases
IgA2 evolved with shorter hinge- present in areas with higher amounts of cleaving pathogens IgA1 more in oral/GI/respiratory mucosa, tonsils, spleen, saliva |
|
NOD receptors act like ________ to sense _______ in the intestinal epithelium
activated in response to ________, leads to ___________ |
act like TLRs to sense toxins
NFkB, leads to inflammation (cytokines + defensins) |
|
why are gamma:delta cells places at the gut epithelial tissue?
forces ____ expression on infected cell leads to: |
- MHC independent, don't want to wait for MHC recognition to start fighting
- forces MIC expression - apoptosis - gamma delta cell helps repair wound |
|
what happens when a cell loses its MHC I receptor?
|
means its been infected
express MIC (NK receptor) induce NK killing |
|
mucosal immunity against worms needs this kind of helper T cell
|
TH2
- don't want to activate complement or macrophages like in TH1 - want B cell activation --> IgE production |
|
once immunized, over time IgM concentration and affinity:
over time IgG concentration and affinity |
stay low
increases, better affinity through somatic hypermutation |
|
will secondary responses produce IgM?
|
- no
|
|
how are naiive B cells inhibited from responding in a secondary response?
why is this important? |
- B cells express FcyRIIB1
- specific IgG binds to these receptors on naiive B cells and inhibit them 1. provide feedback inhibition of an ongoing immune response 2. provide competitive mechanism to drive affinity maturation |
|
RhoGAM prevents against this disease
disease caused by: |
newborn hemolytic anemia
1) Rh- mom reacts to Rh+ from baby, makes IgM (too big to cross barrier to baby), normal baby 2) secondary Rh+ pregnancy, would have high-affinity IgG response to baby, destroy fetal RBCS |
|
how does RhoGAM work
|
1) given during first Rh+ pregnancy
2) is anti- Rh+ IgG 3) since all of moms cells are naiive, it will bind to all of them and inhibit them leading to no response at all |
|
disadvantage to inhibition of naiive B cells in specific response
|
pathogens evolve over time, slow changing of Ags on surface
less and less memory as Ags are mutated and specific Abs can't recognize them, all the while inhibiting naiive cells eventually no Ags will be recognized by memory cells and you have to start all over at a primary response |
|
how do we recognize memory T cells?
|
surface markers differ due to mRNA splicing
CD45RA on naiive CD45RO on memory/effector cells |
|
different fates of naiive T cells
|
straight to memory
- central memory (stay in lymphoid tissue) - effector memory (migrate to tissues) straight to effector cell - then become quiescent memory cell - most effectors die after a few days |
|
3 types of failures of the body's defenses
|
1. evasion/ subversion of our defense system by pathogens
2. inherited deficiencies 3. acquired deficiencies |
|
ways pathogens evade the immune response
|
1. antigenic variation (different serotypes of the same bacteria)
2. antigenic shift (dramatic) 3. latency (herpes) |
|
difference between antigenic drift and shift
|
drift: generation of new viral strains- relatively mild disease epidemics
shift: something we've never seen before. no immunity to a new novel hemagglutinin |
|
primary immunodeficiency disease characterized by lack of Abs
what symptom does it cause (especially by what kind of bacteria?) caused by loss of this in B cells treatment? |
bruton's agammaglobulonemia
recurrent upper respiratory infections- PYOGENIC, polio loss of btk (bruton's tyrosine kinase) --> no B cell development without it Ig given by IV |
|
most common immunodeficiency
what takes its place in the saliva? |
selective IgA deficiency
IgM |
|
What is DiGeorge's syndrome?
developmental or genetic? how are B cells affected? |
lack of thymus, T cell defect
developmental (due to gene deletion- not hereditary) lower levels because you can't make TH2 T Cells - can only have T-independent responses of IgM |
|
characteristics of severe combined immunodeficiency disease (SCID)
how do you treat? |
no T or B cells
life-threatening- bone marrow transplant only treatment |
|
3 gene defects related to SCID
|
1) IL-2 Receptor gamma chain defect (component of cytokine receptors)
2) RAG 1 or 2 3) adenosine deaminase (leads to build up of metabolic products that kill T and B cells) |
|
defect in chronic granulamoatous disease
what cannot be formed |
phagocytic cells can take up microbe but are unable to break them down
- can't form O2 radicals and hydrogen peroxide |
|
2 types of leukocyte adhesion deficiencies
both inhibit: cause widespread: severe ______ disease: |
LAD type I: lack of LFA-1 (integrin) on neutrophils (CD18?)
LAD type II: lack of selectin LIGAND on neutrophils inhibit diapedesis widespread pyogenic bacterial infections periodontal disease |
|
loss of classical complement components leads to:
loss of MBL or alternative complement components leads to: loss of MAC complement components leads to: |
immune complex diseases (often autoimmune such as lupus)
pyogenic bacterial infections or neisseria neisseria infections (gonorrhea, meningitis) |
|
causes hereditary angioedema (HANE)
what does missing component normally do? can be increased by: symptom of concern: |
lack of (or) non-functional C1INH (C1 esterase inhibitor)
normally prevents non-specific activation of C1 stress pharyngeal angioedema- life threatening |
|
bone marrow transplants have been successful in treating:
|
common gamma chain deficiency (SCID), RAG deficiency, ADA deficiency, DiGeorge’s
|
|
3 ways secondary autoimmune diseases can be caused
|
malnutrition (developing countries)
malignancy (problems with infections and immunosuppression caused by treatment or disease) infections (microbe causes- like AIDs) |
|
AIDS is caused by:
infects these types of cells: leads to: |
HIV
CD4+ TH1 and TH2 cells opportunistic infections |
|
when immunosuppressive therapy is used:
therapies used: usually hinder: |
those with autoimmune diseases
those receiving transplants corticosterioids, cyclosporin A, FK506, rapamycin stop T cell-mediated responses more than B cell responses |
|
how does cyclosporin A work?
|
interferes with Il-2, prevents T-cell activation
|
|
caused by microbes usually held in check by the immune system but can be life threatening if you're immunocompromised
|
opportunistic infections (can be parasites, virus, bacterial, fungal)
|
|
4 types of hypersensitivites- which ones are related to antibody?
|
I- allergic/anaphylactic reaction
II- cytotoxic III- immune complex disease IV- cell-mediated delayed hypersensitivity 1st 3 are Ab related |
|
Type I hypersensitivity Ab:
Ab increase can be induced by this factor: antigen often called: common allergens: |
IgE
IL-4 allergen inhaled, injected, ingested |
|
3 features of inhaled allergens that promote priming of TH2 --> IgE release
|
molecular type- proteins, because they only induce T cell response
low dose- favors IL-4 producing T-cells high solubility- allergen is readily eluted from particle |
|
IgE half life
what does it attach to, how, and how long? leads to: |
2 1/2 days
binds to basophils and mast cells through Fc receptor with high affinity- can last for months sensitized to allergen held by IgE, activation of mast cells/ basophils |
|
3 effects of mast cell activation and granule release
what else can interact with mast cells and cause release of mediators? |
GI tract- diarrhea, vomiting
airways- phlegm, coughing blood vessels- edema, inflammation, increased lymph flow anaphylatoxins |
|
Mast Cell preformed mediators and their effects:
newly synthesized mediators and their effects: |
- histamine- capillary dilation, vascular permeability, smooth muscle contraction
- ECF-A- eosinophil chemotactic factor of anaphylaxis Newly synthesized: Leukotrienes- similar to histamine, but even stronger |
|
atopic/ local anaphylaxis
systemic anyaphylaxis genetic component? |
allergic rhinitis (genetic)
asthma (genetic) anaphylactic shock= no genetic component |
|
in chronic asthma, what cell is involved
|
eosinophils- damage airway
|
|
clinical features of anaphylactic shock
occurs how quickly: symptoms in these body areas: death can be caused by: occur due to systemic release of: |
matter of minutes
cardiovascular, respiratory, GI death: laryngeal edema, respiratory failure, shock histamine and leukotrienes |
|
allergy treatment
local: systemic: |
antihistamine
epinephrine (opposite effect of histamine, in epi-pens) |
|
IgE immediate reaction time seen/ late phase:
type III arthus reaction time: type IV delayed reaction time: granuloma reaction time: |
<30 min/ 5 hours
5-6 hrs 24-72 hrs 21-28 days |
|
how does hyposensitization work?
|
- slowly administer allergen to patient
- decrease IgE, increase IgG response - IgG out competes IgE |
|
3 examples of type II sensitivities
|
1. blood transfusion reaction: type A blood given to type B person
2. drug reactions: drug can be hapten, interact with surface protein of cells, induce Ab response 3. autoimmune hemolytic anemia: patient develops Ab against own RBCs |
|
Abs involved in type II sensitivities
how do they work? |
IgM and IgG (complement activators)
Abs bind to hapten on RBC, lead to cell lysis or phagocytosis via complement |
|
how do type III sensitivities work?
Abs involved |
Soluble Ag-Ab complexes circulate throughout the blood stream, settle in certain target organs (kidney) initiating inflammatory response
IgM or IgG |
|
the arthus reaction is _______ induced
Abs are _________, creates Ag-AB complex can activate ____ cells site of rxn will see reaction start in ________ time frame |
locally
Abs are introduced (Ag already there) mast cells --> degranulation --> inflammation on skin 6 hrs |
|
common causes of arthus reactions
|
vaccines
insect stings oral bacteria |
|
major organ targets for systemic type III sensitivities
|
kidneys, joints, heart
|
|
serum sickness
permanent? |
given large does of Antigen (caused by drugs)
complexes settle in your joints(arthritis), kidney (nephritis), heart (vasculitis) accompanied by fever no |
|
3 types of diseases associated with type III hypersensitivities
|
infectious/post infectious disease
autoimmune disease (lupus) drug reactions (serum sickness) |
|
how are complexes removed?
what cells destroy them? works for which Ig: what Ig type does this not work for? |
activate complement
stick to complement receptors on RBCs taken to KUPFFER in liver to remove/destroy works well for IgM/IgG bc they activate complement not good for IgA (tend to settle in organs) |
|
type IV hypersensitivities
site: cells often involved: time of rxn: sometimes involve ______ which can activate CD8 T cells |
skin
TH1 --> cytokines they produce 24-78 hrs can involve haptens soluble enough to bind MHC class I and elicit CD8 T cells response |
|
3 examples of type IV hypersensitivities
how is it tested for? |
1) tuberculin rxn
2) contact dermatitis 3) contact stomatitis (ex. cinnamon) patch test- contains haptens that could create response, leave on for 72 hrs, see response |
|
released by TH1 TCell in type IV
|
chemokines
IFN-gamma TNF-alpha & LT (cytotoxins) |
|
2 phases of type IV hypersensitivity
|
1) sensitization
- hapten makes complex with carrier - picked up/ presented by dendritic cell 2) elicitation phase - effector cells CD4 T cells release cytokines - give response after 24-72 hrs |
|
granuloma is made up of macrophages that have turned into _________ and _______
surrounded by ________ eventually causes death of cells in center of granuloma by |
epithelioid
giant multi-nucleated cells T-cells circulation being cut-off |
|
autoimmunity vs. autoimmune disease
|
response to self-antigen =not harmful
vs. loss of tolerance = harmful |
|
5 mechanisms that contribute to immunological self-tolerance
|
1) negative selection in BM and thymus
2) expression of tissue specific proteins in thymus 3) sequestered Ags (no lymphocyte access) 4) suppression of autoimmune response by Treg cells 5) induction of anergy in autoreactive B/T cells |
|
T regulatory cell surface markers
how does it work? |
CD4
FoxP3 CD25 binds to same APC that autoreactive T-cell is attached to |
|
what happens to autoreactive B cells in periphery
|
bind to autoantigen --> are retained in T-cell area of secondary lymphoid structures --> no T cell help --> die
peripheral tolerance |
|
gender that autoimmune diseases are more prevalent in
|
females
|
|
possible causes of autoimmune diseases
|
1) molecular mimicry
2) breakdown in lymphatic regulation 3) microbes *association but causal not proven* 4) sequestered antigens 5) genetic 6) environmental |
|
when antigens are shared by humans and microbes aka cross-reacting antigens
example |
molecular mimicry
- body response to streptococcus - some Abs will cross-react with myocardial antigen - rheumatic fever |
|
Antigens not exposed to the immune system during immunological development. How might these induce an immune response?
example? |
sequestered antigens
if there is tissue damage, Ag might be exposed sympathetic ophthalmia: damage to one eye leads to release of ntraocular protein antigens --> T cells activated --> attacks both eyes |
|
example of a genetic autoimmune disease?
what immune cell component does it involve? |
ankylosing spondylitis
HLA-B27 |
|
rheumatoid arthritis increases with age due to:
|
involution of thymus and less regulatory T cells
|
|
5 organ specific type II hypersensitivity diseases and causes
|
Hasmimoto's thyroiditis
pemphigus vulgaris: Abs to intercellular substance of the epithelium (ECM) benign mucous membrane pemphigoid: Abs to basement membrane autoimmune hemolytic anemia: Abs to RBCs myasthenia gravis: Abs to acetycholine receptors |
|
3 pathways to destruction in autoimmune hemolytic anemia
|
FcR positive cells in spleen
complement activation in spleen (cells with complement receptor) complement activation and intravascular hemolysis |
|
how can a fetus be affected by myasthenia gravis?
would a fetus be affected by Cell-mediated autoimmundisease from mom? |
baby would get maternal IgG against AChR, eventually get better because the IgG wouldn't last
No- lymphocytes (Tcells) don't cross the placenta |
|
non-organ specific (type III) disease we need to know
organs involved |
systemic lupus
kidney, heart, CN system complexes causing inflammatory response |
|
systemic lupus erythramatosus
makes Abs against (5): consequences (3): |
DNA, ribosomes, histones, snRNP, scRNP
glomerulonephritis, vasculitis, nephritis |
|
T-cell mediated autoimmune disease we need to know (type IV)
autoantigen: consequence: what type of T-cell? |
type I diabetes
pancreatic B-cell antigen Beta-cell destruction = no insulin CD8 cytotoxic |
|
3 rheumatic diseases caused by autoimmunity
|
systemic lupus erythematomus
rheumatoid arthritis ankylosing spondylitis |
|
definition of passive acquired immunity and two types
pros? cons? |
administration of preformed antibodies
natural: placental transfer artificial: anti-toxins, human gammaglobulin pros: cheap, quick acting cons: IMMUNITY IS LIMITED |
|
definition of active acquired immunity and two types
|
when exposed to the microbe or its products
natural: develops after recovering form an infection artificial: toxoids, inactivated or killed vaccines, live attenuated vaccines |
|
vaccine type for each disease
BCG (tuberculosis) diphtheria Hep B influenza measles |
TB: live, attenuated
diphtheria: toxoid Hep B: recombinant viral protein influenza: inactivated virus measles: live, attenuated |
|
what do adjuvants do?
2 ways they do it: ex. |
non-specifically enhance the immune response
1. prolong exposure to Ag 2. initiating an inflammatory response at the site of innoculation ex. ALUM |
|
killed vs. live vaccines
Ag mass: duration of immunity: immunodeficient patient |
small/ large due to proliferation of microbe
short-lived booster/ often life-long usually OK/ risk of disseminated disease often |
|
why is Alum important?
composed of: mechanism of action: |
it's an adjuvant used in the hepatitis B vaccine
aluminum hydroxide gel delays release of Ag, enhanced macrophage uptake |
|
autograft:
isograft: allograft: xenograft: |
same person
identical twin same species, different genetics different species |
|
two types of graft rejections
|
acute: usually mediated by T cells- takes, then turns black later
hyperacute: Ab-mediated, recipient has Abs to donor organ [immediate rejection] looks white- no vascularization at all |
|
occurs when donor lymphocytes in the donor graft attack recipient cells
major problem for: |
graft vs. host disease (GVHD)
bone marrow transplants opposite of transplant rejection |
|
blood transfusion reactions are examples of ______ hypersensitivity
occur when you have a _____ or ____ incompatability |
type II- cytotoxic
ABO or Rh |
|
85% of people are Rh (+ or -)
type of antibody associated with Rh type of antibody associated with ABO typing |
Rh+
IgG (has potential to cross placenta) IgM |
|
one of the most prevalent mucosal diseases in the world
causes an increase in what factor? |
recurrent aphthous stomatitis (canker sores)
TNF-alpha |
|
in pemphigus vulgaris, antibodies are produced against this protein
|
desmoglein 3
|
|
autoimmune disorder directed against exocrine glands particular salivary (________) and lacrimal glands (____________)
|
Sjogrens syndrome
xerostomia keratoconjunctivitis sicca |
|
generally caused by allogenic bone marrow transplantation
how many per year? |
graft vs host disease
>4,000/year |
|
used to detect autoantibodies in tissue (direct/indirect) or seurm (direct/indirect)
|
immunofluorescence for autoimmune disease
tissue = direct serum = indirect |
|
plasma cell dycrasias
2 examples |
group of disorders where there is an abnormal proliferation of a clone Ig secreting cells (usually plasma cells) resulting in the production of monoclonal antibody (M protein)
multiple myeloma and wadenstroms macrogloulinemia |
|
what is an M protein?
how do we test for its presence? |
a monoclonal antibody (created in plasma cell dycrasias)
serum protein electrophoresis [SPE] |
|
symptoms of multiple myeloma
|
bone pain, recurrent infections, mandible involved first, punched out lesions
|
|
test to differentiate between a benign granuloma from a myeloma lesion
|
test for kappa and lambda light chain via immunohistochemical staining
all kappa or all lambda: myeloma lesion a mix of kappa and lambda: benign granuloma |
|
Ig associated with wadenstroms macroglobulinemia
leads to ________ syndrome symptoms seen: treated with: |
IgM
leads to hyperviscosity syndrome [build up of IgM in blood stream] oozing of blood from mucosa, nose bleeding, prolonged bleeding from surgeries, disturbance of vision treated with plasmaphoresis [thins out blood] |
|
technique to differentiate between pemphigus and pemphigoid (type ___ sensitivities)
what are the patterns of each? |
immunofluorescence: use f-Ab against auto-antibody to tell where it's localized (type II)
pemphigus: chicken wire in epithelium pemphigoid: linear appearance at basement membrane |
|
immunofluorescence that shows a bumpy pattern along the basement membrane is characteristic of what disease? what type of hypersensitivity?
|
systemic lupus erythamatosus
type III |
|
concentration of IgM and IgD in
immature B cells leaving the BM immature B cells after alternative splicing mature naiive B cells Ag activated lymphocyte |
IgM only
IgM (high) IgD (low) IgM (low) IgD (high) IgM only |
|
two reversible steps of B-cell receptor/Ab production
|
transcription activation with coexpression of surface IgD and IgM
synthesis changes from membrane Ig to secreted |
|
when does B Cell receptor editing occur and to what?
|
in BM if it's autoreactive- edits the light chain
|
|
present on the surface of central memory cell that isn't on the surface of effector memory cells
|
CCR7
|
|
distinctive features of the mucosal immune system
anatomical features (3) effector mechanisms (2) immunoregulatory environment (2) |
1. intimate interaction between epithelium and lymphoid tissue
2. discrete compartments of diffuse lymphoid tissue and more organized structures such as peyer's patches 3. specialized Ag uptake provided by M cells 1. activated effector T cells predominate even in the absence of infection 2. plasma cells in tissues where Abs are needed 1. active downregulation of inflammatory immune response to food/innocuous antigens 2. inhibitory macrophages and tolerance-inducing dendritic cells |